Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001035006 | SCV001198311 | pathogenic | Hereditary spastic paraplegia 45 | 2019-03-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg367*) in the NT5C2 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with NT5C2-related conditions. Loss-of-function variants in NT5C2 are known to be pathogenic (PMID: 24482476). For these reasons, this variant has been classified as Pathogenic. |
Knight Diagnostic Laboratories, |
RCV001035006 | SCV001448918 | likely pathogenic | Hereditary spastic paraplegia 45 | 2019-05-20 | criteria provided, single submitter | clinical testing |